Schering-Plough's Japanese subsidiary will launch RediTabs imminently, the firm announces. The product is "the first and only allergy product in Japan designed to orally disintegrate," Schering says. The Rx drug's indications mirror those for use in the U.S. The Japanese Ministry of health cleared Claritin for prescription status in 2002 (1"The Tan Sheet" July 15, 2002, In Brief)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights